MYPHARMA
ActiveSummary
MYPHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€5,839) and a net result of -€2,410. Equity is shrinking by about 81% per year across the filed financial years. Its solvency ranks better than 5% of 21,036 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 25 days late
2025
22-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 22 days late
2024
10-09
NBB filing
Annual accounts filed
financial year 2023 · micro format · 41 days late
2023
31-12
Financial
Weakest financial yearnet -€2,423
Net result drops to -€2,423, the lowest in the series; recovery starts the following year.
21-09
NBB filing
Annual accounts filed
financial year 2022 · micro format · 52 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.